Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / ORD SHS
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
8,813,231
-
Shares change
-
-32,561
-
Total reported value, excl. options
-
$143,214,750
-
Value change
-
+$214,441
-
Number of buys
-
29
-
Number of sells
-
-23
-
Price
-
$16.25
Significant Holders of NEURODERM LTD - ORD SHS as of Q2 2016
60 filings reported holding M74231107 - NEURODERM LTD - ORD SHS as of Q2 2016.
NEURODERM LTD - ORD SHS has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,813,231 shares
.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (3,383,358 shares), Redmile Group, LLC (821,445 shares), ACUTA CAPITAL PARTNERS, LLC (634,000 shares), MENORA MIVTACHIM HOLDINGS LTD. (590,724 shares), venBio Select Advisor LLC (557,003 shares), BlackRock Fund Advisors (339,395 shares), BAKER BROS. ADVISORS LP (305,000 shares), PERCEPTIVE ADVISORS LLC (270,000 shares), SPHERA FUNDS MANAGEMENT LTD. (258,513 shares), and Foresite Capital Management III, LLC (201,469 shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.